Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet

Tohoku Journal of Experimental Medicine

Volumn 216, Issue 3, 2008, Pages 249-257

  Koh, Naoki ^a   Sakamoto, Shigeru ^b   Chino, Fumio ^b  

^a Koh Medical Clinic   (Japan)

^b Postmarketing Surveillance and Product Information Department   (Japan)

Author keywords

Alpha glucosidase inhibitor; Diabetes; Glycemic control; Medication compliance; Voglibose

Indexed keywords

ACARBOSE; BIGUANIDE DERIVATIVE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; VOGLIBOSE;

ABDOMINAL DISTENSION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG DOSAGE FORM COMPARISON; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FLATULENCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; SIDE EFFECT;

ADMINISTRATION, ORAL; AGED; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INOSITOL; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TABLETS;

EID: 59849119668     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.216.249     Document Type: Article

References (14)

1. Brown, E.G., Wood, L. & Wood, S. (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf., 20, 109-117.
2. Cramer, J.A. (2004) A systematic review of adherence with medications for diabetes. Diabetes Care, 27, 1218-1224.
3. Goto, Y., Baba, S., Nakagawa, S., Kuzuya, T., Hirata, Y., Akanuma, Y., Sakamoto, N., Shigeta, Y., Tarui, S., Kaneko, T. & Mimura, G. (1992) A study of usefulness of an alpha-glucosidase inhibitor, AO-128, in the treatment period of non-insulin-dependent diabetes mellitus. Clinical phase III, double-blind, intergroup comparative study. Igaku No Ayumi, 160, 943-971 [in Japanese].
4. Japan Diabetes Society. (2007) Clinical Guidelines of Management of Diabetes Based on Clinical Evidences, 2nd ed., Nankodo. Tokyo [in Japanese].
5. Koh, N. (2005) Improvement in medication compliance after treatment of voglibose oral disintegrating tablet. Diabetes Frontier, 16, 119-126 [in Japanese].
6. Matsumoto, K., Yano, M., Miyake, S., Ueki, Y., Yamaguchi, Y., Akazawa, S. & Tominaga, Y. (1998) Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care, 21, 256-260.
7. Ministry of Healt, Labor and Welfare. (2004) Good Post-marketing Study Practice. Kanpou Gougai, 280, 2-5 [in Japanese].
8. 1C after switch from plain tablet to oral dispersing tablet of voglibose, Yakuri to Chiryo, 34, 479-487 [in Japanese with English abstract].
9. Rhee, M.K., Slocum, W., Ziemer, D.C., Culler, S.D., Cook, C.B., El-Kebbi, I.M., Gallina, D.L., Barnes, C. & Phillips, L.S. (2005) Patient adherence improves glycemic control. Diabetes Educ., 31, 240-250.
10. Rozenfeld, Y., Hunt, J.S., Plauschinat, C. & Wong, K.S. (2008) Oral antidiabetic medication adherence and glycemic control in managed care. Am. J. Manag. Care, 14, 71-75.
11. Rubin, R.R. (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am. J. Med., 118, Suppl 5A: 27S-34S.
12. Sokol, M.C., McGuigan, K.A., Verbrugge, R.R. & Epstein, R.S. (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med. Care, 43, 521-530.
13. Wens, J., Vermeire, E., Royen, P.V., Sabbe, B. & Denekens, J. (2005) GPs' perspectives of type 2 diabetes patients' adherence treatment: A qualitative analysis of barriers and solutions. BMC Fam. Pract., 6, 20.
14. Yamaoka, K., Fukuzumi, S., Yosizumi, K., Iguchi, E., Sasaki, M., Nakajima, Y. & Yamauchi, T. (1999) An evaluation of compliance for α-glucosidase inhibitor. Byoin Yakugaku, 25, 204-211 [in Japanese with English abstract].